"Entwicklung von Wachstumsstrategien liegt in unserer DNA"
Lutetium-177 Market Size, Share & Industry Analysis, By Drug (LUTATHERA {lutetium Lu 177 dotatate}, PLUVICTO {lutetium Lu 177 vipivotide tetraxetan}, and Others) By Age Group (Adults and Pediatrics), By Application (Neuroendocrine Tumor, Prostate Cancer, and Others) By End-User (Hospitals, Specialty Clinics, and Andere) und regionale Prognose, 2025-2032
Letzte Aktualisierung: January 19, 2026
| Format: PDF
| Bericht-ID: FBI112740